Small Cell Lung Cancer News and Research

RSS
Small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung. Small cell lung cancer is an aggressive (fast-growing) cancer that can spread to other parts of the body. The cancer cells look small and oval-shaped when looked at under a microscope.
MD Anderson Cancer Center and 4D pharma team up to evaluate live biotherapeutic oncology pipeline

MD Anderson Cancer Center and 4D pharma team up to evaluate live biotherapeutic oncology pipeline

Patients with stage IV disease now living a median 6.8 years after ALK+ NSCLC diagnosis

Patients with stage IV disease now living a median 6.8 years after ALK+ NSCLC diagnosis

FDA approves new drug for treatment of rare autoimmune disorder

FDA approves new drug for treatment of rare autoimmune disorder

UT Southwestern researchers discover enzyme that promotes tumor growth

UT Southwestern researchers discover enzyme that promotes tumor growth

UC San Francisco scientists identify 'Achilles heel' of drug-resistant cancers

UC San Francisco scientists identify 'Achilles heel' of drug-resistant cancers

New nuclear medicine tracer could improve diagnosis, treatment of non-small cell lung cancer

New nuclear medicine tracer could improve diagnosis, treatment of non-small cell lung cancer

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Elderly LS-SCLC patients show similar results to younger counterparts for concurrent chemo-radiotherapy

Elderly LS-SCLC patients show similar results to younger counterparts for concurrent chemo-radiotherapy

Aggressive local therapy for stage IV lung cancer patients improves progression-free survival

Aggressive local therapy for stage IV lung cancer patients improves progression-free survival

SBRT found to be safe treatment for patients with multiple metastases

SBRT found to be safe treatment for patients with multiple metastases

Advanced breast cancer patients can benefit from immunotherapy-chemotherapy combination

Advanced breast cancer patients can benefit from immunotherapy-chemotherapy combination

Forbius initiates Phase 2a trial evaluating efficacy, safety of AVID100 in patients with squamous NSCLC

Forbius initiates Phase 2a trial evaluating efficacy, safety of AVID100 in patients with squamous NSCLC

NCI grant awarded to Abramson Cancer Center to study CAR T cells In solid tumors

NCI grant awarded to Abramson Cancer Center to study CAR T cells In solid tumors

Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Study: Erlotinib improves progression-free survival in EGFR mutated NSCLC

Study: Erlotinib improves progression-free survival in EGFR mutated NSCLC

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

New approach to understanding cancers will accelerate development of better treatments

New approach to understanding cancers will accelerate development of better treatments